Rhythm Pharmaceuticals Presents New Disease Burden Findings

-- CARE-BBS multi-country survey of 242 caregivers of individuals with Bardet-Biedl syndrome (BBS) provides extensive details on impact of hyperphagia and...

Related Keywords

Rome ,Lazio ,Italy ,Germany ,United States ,Argente ,Comunidad Autonoma De Aragon ,Spain ,United Kingdom ,Madrid ,Boston ,Massachusetts ,Canada ,London ,City Of ,Elizabeth Forsythe ,David Meeker ,European Commission ,Drug Administration ,Rhythm Pharmaceuticals ,Nasdaq ,United Kingdom Medicines Healthcare Products Regulatory Agency ,Rhythm Pharmaceuticals Inc ,European Union ,Department Of Pediatrics ,Institute Of Child Health ,Annual Meeting ,European Society ,Paediatric Endocrinology ,Ormond Street Institute ,Child Health ,Chief Executive Officer ,Multifaceted Burden Experienced ,Bardet Biedl Syndrome ,Hyperphagia Impacts ,Pediatric Endocrinology ,Universidad Aut ,Setmelanotide Treatment ,Leptin Receptor ,Open Label Trial ,Pediatric Patients Aged ,Healthcare Products Regulatory Agency ,Rhythm Engine ,Nasdaq Rytm ,Nc ,